#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Staphylococcal infection Ovarian cancer stage IV Aicardi-Goutieres syndrome Endometrial cancer Osteochondrodysplasia Neuroblastoma recurrent Uveal melanoma Spina bifida Chronic graft versus host disease Cardiomyopathy Ewing's sarcoma Juvenile chronic myelomonocytic leukaemia Liposarcoma recurrent Soft tissue necrosis Palmar-plantar erythrodysaesthesia syndrome More trials…

    Learn about Rare Diseases

    Sarcoma – Trials in Disease Shprintzen-Goldberg syndrome – Diagnostics Undifferentiated sarcoma – Trials in Disease Rhabdomyosarcoma recurrent – Basic Information Andersen-Tawil syndrome – Treatment Angiosarcoma non-metastatic Rett syndrome – Trials in Disease Antisynthetase syndrome – Basic Information Hypereosinophilic syndrome – Trials in Disease Alternating hemiplegia of childhood – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Charcoal, Activated Metyrapone Rupatadine Paclitaxel Albumin-Bound Dazucorilant TRAZODONE HYDROCHLORIDE Metoclopramide Hydrochloride ULEFNERSEN SODIUM BENZOATE Nizaracianine Triflutate Suvecaltamide Tinengotinib Sabestomig Flecainide Acetate Dextrose Bp Ferrous Sulfate Festuca Elatior Pollen Extract Adezunap Ltx-315 Vibostolimab More therapies…

    Learn about Your Condition

    Postoperative wound infection Post procedural swelling Microvillous inclusion disease Psychogenic seizure Pneumonia chlamydial Rett syndrome Familial hypertriglyceridaemia Fallopian tube cancer Laryngeal leukoplakia Dystonia Cystic fibrosis lung Perinatal depression Liposarcoma recurrent Cortisol abnormal Colon cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centrum für Hämatologie und Onkologie am Bethanien-Krankenhaus…

Centrum für Hämatologie und Onkologie am Bethanien-Krankenhaus

Im Prüfling 17-19, Frankfurt, 60389, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Comparison of intravenous versus subcutaneous isatuximab with lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma patients eligible for transplant

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Betamethasone Sodium Phosphate
    • Bortezomib
    • Isatuximab
    Austria Germany

  • Study of Capivasertib and Fulvestrant for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Capivasertib
    • Fulvestrant
    Belgium France Germany Hungary Italy Poland +1

  • Study on Atezolizumab and Chemotherapy for Patients with Triple-Negative Breast Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Atezolizumab
    • Carboplatin
    • Cyclophosphamide
    Germany Spain

  • Study on Daratumumab with Bortezomib, Cyclophosphamide, and Dexamethasone for Multiple Myeloma Patients Not Eligible for Transplant

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Daratumumab
    Germany

  • Study on Abemaciclib with Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer at Intermediate to High Risk

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Human epidermal growth factor receptor negative
    • Hormone receptor positive breast cancer
    • Breast cancer
    Investigated Drugs:
    • Abemaciclib
    Germany Poland Spain
Previous Page
1 2

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!